Schrödinger, Inc. is an international scientific software company specializing in developing computational tools and software for drug discovery and materials science. Their software is used by pharmaceutical companies, biotech firms, and academic researchers to simulate and model the behavior of molecules at the atomic level, accelerating the design and development of new drugs and materials more efficiently, reducing time and cost.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

COM:SCHRODINGER

Schrödinger, Inc.

Last Close

20.37

22/11 21:00

Market Cap

1.42B

Beta: -

Volume Today

623.61K

Avg: -

Analysis Not Available